Globus Medical, Inc.

Globus Medical, Inc.

GMED

$74.29

Updated: 22/09/2026, 15:10:37

Market Cap
$10.02B
Sector
Healthcare
Industry
Medical - Devices
Country
US
Stock valuation chart
One-year closing share-price history for GMED
Company Profile

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.

USD
NYSE
CEO: Keith W. Pfeil
Employees: 6,000
https://www.globusmedical.com
Asset Summaries
Latest generated summaries for GMED

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for GMED.
Share price
$74.29
Market cap
$10.02B
Exchange
NYSE
Currency
USD
CEO
Keith W. Pfeil
Employees
6,000
IPO date
03/08/2012
Beta
0.956
Last dividend
$0.00
Day range
$73.59 – $74.41
52-week range
$54.15 – $101.40
1-day performance
0.28%
1-year performance
37.19%
Current drawdown (1Y)
-26.74%
CIK
0001237831
CUSIP
379577208
ISIN
US3795772082
Created
07/12/2025, 04:22:17
Last update
22/09/2026, 15:10:37

Track Globus Medical, Inc. with an AI analyst

See which prediction-market events move GMED, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to GMED from your Railway `news_articles` table.

Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom

Zacks Investment Research • STOCK • 09/06/2026, 13:06:00

Does Globus Medical (GMED) Have the Potential to Rally 38.85% as Wall Street Analysts Expect?

Zacks Investment Research • STOCK • 08/06/2026, 12:56:34

GMED or PEN: Which Is the Better Value Stock Right Now?

Zacks Investment Research • STOCK • 05/06/2026, 14:40:28

Here's How Financial Strength Remains a Key Advantage for GMED

Zacks Investment Research • STOCK • 04/06/2026, 14:55:28

Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?

Zacks Investment Research • STOCK • 02/06/2026, 13:30:28

GMED's Robotics Leasing Shift Could Build Recurring Revenue

Zacks Investment Research • STOCK • 29/05/2026, 12:55:31

Looking for a Growth Stock? 3 Reasons Why Globus Medical (GMED) is a Solid Choice

Zacks Investment Research • STOCK • 27/05/2026, 15:46:18

Globus Medical (GMED) Upgraded to Strong Buy: Here's What You Should Know

Zacks Investment Research • STOCK • 27/05/2026, 15:01:17

GMED vs. SONVY: Which Stock Is the Better Value Option?

Zacks Investment Research • STOCK • 20/05/2026, 14:40:26

Why Globus Medical (GMED) is a Top Value Stock for the Long-Term

Zacks Investment Research • STOCK • 20/05/2026, 12:40:27

3 Reasons Why Growth Investors Shouldn't Overlook Globus Medical (GMED)

Zacks Investment Research • STOCK • 11/05/2026, 15:46:07

Down 13.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Globus Medical (GMED)

Zacks Investment Research • STOCK • 11/05/2026, 12:35:30